MANFREDI, Andreina Teresa
 Distribuzione geografica
Continente #
NA - Nord America 21.550
EU - Europa 14.018
AS - Asia 9.781
SA - Sud America 1.397
Continente sconosciuto - Info sul continente non disponibili 472
AF - Africa 286
OC - Oceania 100
Totale 47.604
Nazione #
US - Stati Uniti d'America 20.996
IT - Italia 7.206
SG - Singapore 2.961
GB - Regno Unito 2.415
CN - Cina 2.390
HK - Hong Kong 1.070
BR - Brasile 1.033
SE - Svezia 977
VN - Vietnam 969
DE - Germania 616
FR - Francia 555
FI - Finlandia 530
BD - Bangladesh 509
UA - Ucraina 377
TR - Turchia 376
RU - Federazione Russa 374
KR - Corea 275
CA - Canada 270
IN - India 262
JP - Giappone 226
NL - Olanda 208
ID - Indonesia 201
MX - Messico 193
IE - Irlanda 163
BG - Bulgaria 161
AR - Argentina 135
AU - Australia 92
ZA - Sudafrica 89
IQ - Iraq 77
PK - Pakistan 76
PL - Polonia 75
AE - Emirati Arabi Uniti 63
TN - Tunisia 58
EC - Ecuador 55
ES - Italia 53
MY - Malesia 50
CH - Svizzera 43
CL - Cile 43
CO - Colombia 42
LT - Lituania 42
BE - Belgio 35
PH - Filippine 34
IR - Iran 33
SA - Arabia Saudita 33
EG - Egitto 31
MA - Marocco 31
AT - Austria 28
PE - Perù 28
VE - Venezuela 28
UZ - Uzbekistan 23
RO - Romania 22
TH - Thailandia 22
HU - Ungheria 21
JO - Giordania 21
NP - Nepal 21
DZ - Algeria 20
BZ - Belize 19
KE - Kenya 19
PT - Portogallo 17
EU - Europa 16
TW - Taiwan 15
PY - Paraguay 14
TT - Trinidad e Tobago 13
DK - Danimarca 12
AZ - Azerbaigian 11
BO - Bolivia 11
DO - Repubblica Dominicana 11
IL - Israele 10
HN - Honduras 9
HR - Croazia 9
RS - Serbia 9
CR - Costa Rica 8
GR - Grecia 8
MD - Moldavia 8
NZ - Nuova Zelanda 8
AL - Albania 7
CZ - Repubblica Ceca 7
ET - Etiopia 7
LV - Lettonia 7
JM - Giamaica 6
KG - Kirghizistan 6
LB - Libano 6
LU - Lussemburgo 6
NI - Nicaragua 6
NO - Norvegia 6
OM - Oman 6
PA - Panama 6
BY - Bielorussia 5
CY - Cipro 5
KZ - Kazakistan 5
QA - Qatar 5
SI - Slovenia 5
UY - Uruguay 5
GT - Guatemala 4
KW - Kuwait 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
GY - Guiana 3
ML - Mali 3
PS - Palestinian Territory 3
Totale 47.095
Città #
Santa Clara 2.054
Singapore 2.030
Ashburn 1.825
Fairfield 1.722
Southend 1.515
Hong Kong 1.039
Woodbridge 941
Chandler 917
San Jose 800
Houston 758
Chicago 663
Wilmington 637
Hefei 619
Seattle 591
Jacksonville 566
Milan 550
Los Angeles 549
Cambridge 533
Ann Arbor 531
Nyköping 513
Rome 497
Council Bluffs 475
London 448
Beijing 423
Helsinki 407
Dearborn 387
The Dalles 348
New York 323
Ho Chi Minh City 291
Salt Lake City 274
Modena 250
Seoul 236
Hanoi 233
San Diego 182
Izmir 181
Dallas 165
Sofia 152
Princeton 147
Jakarta 135
Buffalo 133
Redwood City 132
Tampa 130
Bologna 129
Dublin 127
Florence 123
Lauterbourg 122
Naples 120
Elk Grove Village 119
Eugene 113
Shanghai 113
São Paulo 108
Palermo 107
Bari 106
Moscow 100
Frankfurt am Main 97
Tokyo 97
Catania 83
Bremen 77
Falls Church 71
Genoa 70
Orem 69
Toronto 68
Boardman 67
Mexico City 64
Turin 63
Verona 63
Phoenix 59
Des Moines 57
Sterling 57
Munich 56
Columbus 55
Da Nang 54
Lancaster 51
Padova 50
Chennai 47
Montreal 47
Perth 47
Miami 45
Guangzhou 44
Atlanta 43
Cagliari 41
Johannesburg 41
Manchester 40
Brooklyn 39
San Francisco 39
Warsaw 38
Denver 37
Mumbai 36
Parma 36
Amsterdam 35
Dulles 34
Paris 34
Ankara 33
Haiphong 32
Ottawa 32
Detroit 31
Redondo Beach 31
Dong Ket 30
Messina 30
Salerno 30
Totale 28.989
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.870
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.372
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.330
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 966
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 803
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 487
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 464
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 449
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 443
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 417
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 408
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 392
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 392
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 387
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 374
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 374
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 372
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 371
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 365
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 363
Current treatment of hepatitis C-associated rheumatic diseases. 359
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 358
Cardiac Involvement in Systemic Vasculitis 354
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 350
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 349
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 348
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 347
Scleroderma digital ulcers complicated by infection with fecal pathogens. 346
Aortic pulse wave velocity measurement in systemic sclerosis patients. 344
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 341
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 327
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 327
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 326
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 326
Acute exacerbation of interstitial lung disease associated with rheumatic disease 326
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 324
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 322
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 321
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 319
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 319
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 316
Platelet gel in the treatment of severe scleroderma skin ulcers. 312
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 311
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 311
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 310
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 303
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 303
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 298
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 295
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 292
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 292
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 291
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 288
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 287
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 286
Cardiovascular risk and prostanoids in systemic sclerosis 285
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 285
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 281
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 278
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 276
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 276
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 276
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 274
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 272
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 263
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 259
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 259
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 255
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 253
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 253
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 248
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 247
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 246
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 244
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 243
Osteomyelitis complicating scleroderma digital ulcers. 243
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 241
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 240
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 240
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 240
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 239
Procedural pain management in the treatment of scleroderma digital ulcers 232
NAILFOLD VIDEOCAPILLAROSCOPY FEATURES OF PATIENTS WITH ANTISYNTHETASE SYNDROME 230
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 230
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 229
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 229
Nailfold videocapillaroscopy in antisynthetase syndrome 229
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 228
Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne [Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis] 224
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 223
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 220
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 220
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 219
Mixed cryoglobulinemia syndrome: where are we going to? 218
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 215
A new chance to treat rheumatoid arthritis lung fibrosis? 214
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 209
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 205
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 205
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 204
Totale 36.526
Categoria #
all - tutte 178.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.280 0 277 265 268 170 287 182 196 389 316 512 418
2022/20234.459 457 336 271 316 439 532 264 438 536 204 391 275
2023/20244.240 221 274 279 454 574 346 356 548 153 240 343 452
2024/20258.032 334 198 231 585 1.540 1.135 590 418 821 423 794 963
2025/202615.319 800 516 1.011 2.020 3.042 1.045 1.737 647 1.320 1.171 1.098 912
2026/2027589 561 28 0 0 0 0 0 0 0 0 0 0
Totale 47.604